Wright Medical Q2 Loss Widens - Quick Facts

(RTTNews) - Wright Medical Group, Inc. (WMGI) reported that its second-quarter loss from continuing operations widened to $53.58 million or $1.08 per share, from a loss of $15.54 million or $0.34 per share, prior year. Net loss per share was $1.13, compared to a loss of $0.37, a year ago.

Net loss from continuing operations, as adjusted, was $24.0 million, or $0.48 per share in the second quarter of 2014.

On average, 14 analysts polled by Thomson Reuters expected the company to report a loss per share of $0.45 for the quarter. Analysts' estimates typically exclude special items.

Net sales increased to $72.36 million from $60.57 million. Analysts expected revenue of $74.17 million for the quarter.

The company reiterated its previous guidance range for net sales from continuing operations, or Extremity and Biologics revenue, for 2014 of approximately $308 million to $312 million. The company also reiterated its previously issued adjusted loss per share from continuing operations, including stock-based compensation, for full-year 2014 of $1.28 to $1.38. Analysts expect the company to report 2014 loss per share of $1.32 on revenue of $310.46 million.